These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 37003902)
1. Perniosis-like erythema after SARS-CoV2 infection reactivated by vaccination with inactivated virus. Campos Garcia L; Barcelos VM; Macedo de Alcântara M; Valadares PJC An Bras Dermatol; 2023; 98(4):552-554. PubMed ID: 37003902 [No Abstract] [Full Text] [Related]
2. Perniosis-like lesions after vaccination with mRNA against COVID-19. Pérez-López I; Gil-Villalba A; Ruiz-Villaverde R Med Clin (Barc); 2022 Feb; 158(4):189-190. PubMed ID: 34229882 [No Abstract] [Full Text] [Related]
3. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. Ko CJ; Harigopal M; Damsky W; Gehlhausen JR; Bosenberg M; Patrignelli R; McNiff JM J Cutan Pathol; 2020 Nov; 47(11):997-1002. PubMed ID: 32745281 [TBL] [Abstract][Full Text] [Related]
4. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Magro CM; Mulvey JJ; Laurence J; Sanders S; Crowson AN; Grossman M; Harp J; Nuovo G Br J Dermatol; 2021 Jan; 184(1):141-150. PubMed ID: 32779733 [TBL] [Abstract][Full Text] [Related]
5. Erythematous-edematous type of chilblain-like lesions and COVID-19: An Indian perspective. Das A; Singh V Dermatol Ther; 2020 Nov; 33(6):e13912. PubMed ID: 32594608 [No Abstract] [Full Text] [Related]
6. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text]. Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218 [TBL] [Abstract][Full Text] [Related]
7. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study. Poizeau F; Oger E; Barbarot S; Le Corre Y; Samimi M; Brenaut E; Aubert H; Chambrelan E; Droitcourt C; Gissot V; Heslan C; Laurent C; Martin L; Misery L; Tattevin P; Toubel A; Thibault V; Dupuy A Clin Microbiol Infect; 2022 Feb; 28(2):285-291. PubMed ID: 34619397 [TBL] [Abstract][Full Text] [Related]
8. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains. De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533 [TBL] [Abstract][Full Text] [Related]
9. Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination. Temiz SA; Abdelmaksoud A; Dursun R; Vestita M Int J Dermatol; 2021 Sep; 60(9):1152-1153. PubMed ID: 33900629 [No Abstract] [Full Text] [Related]
10. Auricle perniosis as a manifestation of Covid-19 infection. Proietti I; Tolino E; Bernardini N; Mambrin A; Balduzzi V; Marchesiello A; Michelini S; Del Borgo C; Skroza N; Lichtner M; Potenza C Dermatol Ther; 2020 Nov; 33(6):e14089. PubMed ID: 32720420 [No Abstract] [Full Text] [Related]
11. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567 [TBL] [Abstract][Full Text] [Related]
12. Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association? Karamanakos A; Evangelatos G; Pappa M; Fragiadaki K; Fanouriakis A; Fragoulis GE J Rheumatol; 2022 Nov; 49(11):1295-1296. PubMed ID: 35914789 [No Abstract] [Full Text] [Related]
13. Erythema multiforme-like lesions in children and COVID-19. Torrelo A; Andina D; Santonja C; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I Pediatr Dermatol; 2020 May; 37(3):442-446. PubMed ID: 32445583 [TBL] [Abstract][Full Text] [Related]
14. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience. Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M Front Immunol; 2023; 14():1106472. PubMed ID: 36761740 [TBL] [Abstract][Full Text] [Related]